EAM Investors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-218,429
Closed -$1.39M 331
2018
Q2
$1.39M Sell
218,429
-100,758
-32% -$641K 0.22% 175
2018
Q1
$1.51M Buy
+319,187
New +$1.51M 0.25% 160
2014
Q2
Sell
-161,935
Closed -$2.48M 335
2014
Q1
$2.48M Buy
+161,935
New +$2.48M 0.45% 53
2013
Q4
Sell
-152,854
Closed -$1.52M 328
2013
Q3
$1.52M Buy
+152,854
New +$1.52M 0.3% 119